Ontology highlight
ABSTRACT:
SUBMITTER: Amin Al Olama A
PROVIDER: S-EPMC4491026 | biostudies-literature | 2015 Jul
REPOSITORIES: biostudies-literature
Amin Al Olama Ali A Benlloch Sara S Antoniou Antonis C AC Giles Graham G GG Severi Gianluca G Neal David E DE Hamdy Freddie C FC Donovan Jenny L JL Muir Kenneth K Schleutker Johanna J Henderson Brian E BE Haiman Christopher A CA Schumacher Fredrick R FR Pashayan Nora N Pharoah Paul D P PD Ostrander Elaine A EA Stanford Janet L JL Batra Jyotsna J Clements Judith A JA Chambers Suzanne K SK Weischer Maren M Nordestgaard Børge G BG Ingles Sue A SA Sorensen Karina D KD Orntoft Torben F TF Park Jong Y JY Cybulski Cezary C Maier Christiane C Doerk Thilo T Dickinson Joanne L JL Cannon-Albright Lisa L Brenner Hermann H Rebbeck Timothy R TR Zeigler-Johnson Charnita C Habuchi Tomonori T Thibodeau Stephen N SN Cooney Kathleen A KA Chappuis Pierre O PO Hutter Pierre P Kaneva Radka P RP Foulkes William D WD Zeegers Maurice P MP Lu Yong-Jie YJ Zhang Hong-Wei HW Stephenson Robert R Cox Angela A Southey Melissa C MC Spurdle Amanda B AB FitzGerald Liesel L Leongamornlert Daniel D Saunders Edward E Tymrakiewicz Malgorzata M Guy Michelle M Dadaev Tokhir T Little Sarah J SJ Govindasami Koveela K Sawyer Emma E Wilkinson Rosemary R Herkommer Kathleen K Hopper John L JL Lophatonanon Aritaya A Rinckleb Antje E AE Kote-Jarai Zsofia Z Eeles Rosalind A RA Easton Douglas F DF
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20150402 7
<h4>Background</h4>Genome-wide association studies have identified multiple genetic variants associated with prostate cancer risk which explain a substantial proportion of familial relative risk. These variants can be used to stratify individuals by their risk of prostate cancer.<h4>Methods</h4>We genotyped 25 prostate cancer susceptibility loci in 40,414 individuals and derived a polygenic risk score (PRS). We estimated empirical odds ratios (OR) for prostate cancer associated with different ri ...[more]